相似文献
1
Big Data Approaches for Modeling Response and Resistance to Cancer Drugs.
Annu Rev Biomed Data Sci. 2018 Jul;1:1-27. doi: 10.1146/annurev-biodatasci-080917-013350. Epub 2018 Apr 25.
2
Big science and big data in nephrology.
Kidney Int. 2019 Jun;95(6):1326-1337. doi: 10.1016/j.kint.2018.11.048. Epub 2019 Mar 5.
3
[Development of antituberculous drugs: current status and future prospects].
Kekkaku. 2006 Dec;81(12):753-74.
4
The Scope of Big Data in One Medicine: Unprecedented Opportunities and Challenges.
Front Vet Sci. 2017 Nov 16;4:194. doi: 10.3389/fvets.2017.00194. eCollection 2017.
5
Big data in basic and translational cancer research.
Nat Rev Cancer. 2022 Nov;22(11):625-639. doi: 10.1038/s41568-022-00502-0. Epub 2022 Sep 5.
6
The Use of Big Data in Personalized Healthcare to Reduce Inventory Waste and Optimize Patient Treatment.
J Pers Med. 2024 Apr 3;14(4):383. doi: 10.3390/jpm14040383.
7
-Omic and Electronic Health Record Big Data Analytics for Precision Medicine.
IEEE Trans Biomed Eng. 2017 Feb;64(2):263-273. doi: 10.1109/TBME.2016.2573285. Epub 2016 Oct 10.
8
Computer-aided biomarker discovery for precision medicine: data resources, models and applications.
Brief Bioinform. 2019 May 21;20(3):952-975. doi: 10.1093/bib/bbx158.
9
Targeted therapy in cancer.
Cancer Chemother Pharmacol. 2015 Dec;76(6):1113-32. doi: 10.1007/s00280-015-2861-1. Epub 2015 Sep 21.
10
Human Microbiome and Learning Healthcare Systems: Integrating Research and Precision Medicine for Inflammatory Bowel Disease.
OMICS. 2018 Feb;22(2):119-126. doi: 10.1089/omi.2016.0185. Epub 2017 Mar 10.
引用本文的文献
1
The present and future of the Cancer Dependency Map.
Nat Rev Cancer. 2025 Jan;25(1):59-73. doi: 10.1038/s41568-024-00763-x. Epub 2024 Oct 28.
2
Integrative Bioinformatics Analysis: Unraveling Variant Signatures and Single-Nucleotide Polymorphism Markers Associated with 5-FU-Based Chemotherapy Resistance in Colorectal Cancer Patients.
J Gastrointest Cancer. 2024 Dec;55(4):1607-1619. doi: 10.1007/s12029-024-01102-x. Epub 2024 Sep 6.
3
Preclinical-to-clinical Anti-cancer Drug Response Prediction and Biomarker Identification Using TINDL.
Genomics Proteomics Bioinformatics. 2023 Jun;21(3):535-550. doi: 10.1016/j.gpb.2023.01.006. Epub 2023 Feb 11.
4
Big data in basic and translational cancer research.
Nat Rev Cancer. 2022 Nov;22(11):625-639. doi: 10.1038/s41568-022-00502-0. Epub 2022 Sep 5.
5
Systematic investigation of cytokine signaling activity at the tissue and single-cell levels.
Nat Methods. 2021 Oct;18(10):1181-1191. doi: 10.1038/s41592-021-01274-5. Epub 2021 Sep 30.
6
Spike-in normalization for single-cell RNA-seq reveals dynamic global transcriptional activity mediating anticancer drug response.
NAR Genom Bioinform. 2021 Jun 17;3(2):lqab054. doi: 10.1093/nargab/lqab054. eCollection 2021 Jun.
7
Systematic prediction of drug resistance caused by transporter genes in cancer cells.
Sci Rep. 2021 Apr 1;11(1):7400. doi: 10.1038/s41598-021-86921-9.
8
The promise and challenge of cancer microbiome research.
Genome Biol. 2020 Jun 2;21(1):131. doi: 10.1186/s13059-020-02037-9.
9
Tissue-guided LASSO for prediction of clinical drug response using preclinical samples.
PLoS Comput Biol. 2020 Jan 22;16(1):e1007607. doi: 10.1371/journal.pcbi.1007607. eCollection 2020 Jan.
10
pathCHEMO, a generalizable computational framework uncovers molecular pathways of chemoresistance in lung adenocarcinoma.
Commun Biol. 2019 Sep 6;2:334. doi: 10.1038/s42003-019-0572-6. eCollection 2019.
本文引用的文献
1
Genome-Scale Signatures of Gene Interaction from Compound Screens Predict Clinical Efficacy of Targeted Cancer Therapies.
Cell Syst. 2018 Mar 28;6(3):343-354.e5. doi: 10.1016/j.cels.2018.01.009. Epub 2018 Feb 7.
2
The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients.
Science. 2018 Jan 5;359(6371):104-108. doi: 10.1126/science.aao3290.
3
A major chromatin regulator determines resistance of tumor cells to T cell-mediated killing.
Science. 2018 Feb 16;359(6377):770-775. doi: 10.1126/science.aao1710. Epub 2018 Jan 4.
4
Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer.
Cell. 2017 Dec 14;171(7):1611-1624.e24. doi: 10.1016/j.cell.2017.10.044. Epub 2017 Nov 30.
5
Analysis of persistence and antibiotic response in colorectal cancer.
Science. 2017 Dec 15;358(6369):1443-1448. doi: 10.1126/science.aal5240. Epub 2017 Nov 23.
6
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors.
Science. 2018 Jan 5;359(6371):91-97. doi: 10.1126/science.aan3706. Epub 2017 Nov 2.
7
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients.
Science. 2018 Jan 5;359(6371):97-103. doi: 10.1126/science.aan4236. Epub 2017 Nov 2.
8
Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells.
Nat Genet. 2017 Dec;49(12):1779-1784. doi: 10.1038/ng.3984. Epub 2017 Oct 30.
9
Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab.
Cell. 2017 Nov 2;171(4):934-949.e16. doi: 10.1016/j.cell.2017.09.028. Epub 2017 Oct 12.
10
Legacy data sharing to improve drug safety assessment: the eTOX project.
Nat Rev Drug Discov. 2017 Dec;16(12):811-812. doi: 10.1038/nrd.2017.177. Epub 2017 Oct 13.
Zotero 插件